Results: HIV infected individuals had a higher (20.2%) prevalence of Tuberculosis compared to those who were negative for HIV (3.2%).
Introduction
There is a growing number of individuals with HIV/Tuberculosis co-infections, posing several challenges in early recognition, diagnosis, prevention, prophylaxis and treatment of tuberculosis.
Diagnosis of TB in HIV/AIDS patients can be difficult as most of the potentially used diagnostic tests are usually negative or atypical. This poses a diagnostic challenge that is yet to be resolved. On the other hand treatment of TB in patients with symptomatic HIV infection can be a challenge mainly because of interactions among drugs used for TB. There is no best approach to this so far. Likewise the prevalence of adverse reactions to anti-TB medications is not clearly known in Tanzania. The overall survival rate for patients with TB-HIV co-infection is also unknown.
Methodology
This retrospective, cross-sectional study was hospital based and conducted for a period of 6 
Results
Our study recruited 1318 patients. It also revealed that HIV infected patients had a significantly higher prevalence (20.2%) of tuberculosis compared to those individuals who were negative for HIV (3.2%).
The most commonly used diagnostic methods included chest radiographs, sputum smears and tuberculin skin tests. Sputum cultures were also done in these clinics Chest radiographs were found to be atypical in most of the patients who were positive for HIV (32.7%) Sputum smears were found to be negative in 19.2% of the patients who were found to be positive for TB through other tests.
The study also found that treatment for Tuberculosis and AIDS depends on the CD4 levels and that TB was treated first before HAART in the case where CD4 were < 200. Anti-TB was administered for a short while until patients were stable. Almost all (90.9%) patients with CD4 <50 were not using anti-TB therapy at the time of the study but they had a history of being treated for TB earlier before the start of ARVs. No side effects from drug therapy were observed in all the patients involved in this study. From the figure no.1 (above), the prevalence rate of HIV/TB co-infection in this study population was found to be 20.2%. The table also shows that the prevalence of HIV infection was 26.3% while that of TB was 7.7%. Mycobacterium tuberculosis organisms that were subsequently sub-cultured in media containing the specific anti-tuberculosis drugs. It was found that the isolated M. tuberculosis was sensitive to the tested anti-tuberculosis drugs in all the subcultures, signifying absence of primary drug resistance with these isolates.
Discussion
The HIV and tuberculosis epidemics are fueling each other, creating a public health crisis of enormous proportions.
1 HIV destroys the body's immune system and makes the individual prone to opportunistic infections (e.g. TB). Patients with HIV/AIDS can develop active tuberculosis either as a result of re-activation of their chronic latent TB or by acquiring new infections from the environment. 2 In this study, it was found that HIV infected individuals had a higher (20.2%) prevalence of TB compared to those individuals who were negative for HIV (3.2%).This study results were found to be similar to findings from earlier study done in Tanzania that revealed among patients with sputum positive results for Pulmonary TB, 35.8% were seropositive for HIV 3 . The study is also consistent to findings from the Dominican republic (a tropical country that is endemic for TB) which found the prevalence rates of 15% and 5% respectively 4 . However, the study shows a discrepancy from studies of other East African countries as evidence from studies done in Uganda and Kenya reveals 5 . One study done in Uganda revealed that only 2.6% of individuals reported to have TB-HIV co-infection. Another study done in Kenya revealed that 19% of HIV positive individuals had tuberculosis also.
From the study it was also found that many of the diagnostic modalities have shortcomings in diagnosing TB associated with HIV.
Chest radiography was found to be atypical in most patients who were positive for HIV 17 (32.7%). This is in accordance with the study done in Tanzania that noted people with HIV infections to have atypical chest radiographs 3 .
Typical reactivation of tuberculosis on chest x-rays was found in 51% of the HIV positive Tuberculosis patients 3 . It was observed that 90.9% of patients who had CD4 counts >50 were not on Tuberculosis regimen (DOTS).This is because some were on short period of AntiTuberculosis regimen before it was stopped for them to start HAART regimen. It was observed that 100% of patients with CD4 >200 were on DOTS regimens without HAART.
The study revealed that tuberculosis was treated first before initiation of HAART for at least a short while until the patient was stabilized. This is in accordance to the WHO guidelines that suggest that TB treatment must be given urgently in cases of severe immunocompromised HIV infection candidates 5 .
The urgency of HIV treatment depends on predictors of HIV disease progression (HIV RNA level, CD4 cell count, prior HIV-related diagnoses).
Options . Rifampin was the commonly implicated drug, producing an adverse reaction in 12% of the patients 5 . In the Democratic Republic of Congo (then Zaire), 11% of the seropositive cases developed a rash, but treatment was not interrupted. 5 However this may not reflect what is in the general population taking into account of the small sample size. Similar findings were also found in another study done in 1993 in rural Iringa that found all culture positive samples samples 13.2% were sensitive to the tested anti-tuberculosis medications.
Low levels of resistance have been reported in Tanzania whereby it was found that about 90% of all newly diagnosed sputum smear positive cases are sensitive to streptomycin, isoniazid and thiacetazone 3 . Only in 8% were the bacilli resistant to isoniazid, In about 1-2% to streptomycin and in a further 1-2% to isoniazid and streptomycin while the resistance to rifampicin is very low (1%) 3 .
No mortality were observed in the whole course of the study. This is in opposition to several studies which revealed that there are usually high mortality in HIV -Tb coinfected patients of up to 35%.
